tiprankstipranks
Emmaus Life Sciences Inc (EMMA)
OTHER OTC:EMMA
US Market

Emmaus Life Sciences (EMMA) Stock Price & Analysis

85 Followers

EMMA Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.05 - $0.29
Previous Close$0.09
Volume97.09K
Average Volume (3M)7.60K
Market Cap
$4.88M
Enterprise Value$36.22M
Total Cash (Recent Filing)$1.36M
Total Debt (Recent Filing)$32.67M
Price to Earnings (P/E)
Beta1.69
Aug 12, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding53,637,554
10 Day Avg. Volume6,636
30 Day Avg. Volume7,596
Standard Deviation0.32
R-Squared0.07
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)-0.14
Price to Sales (P/S)0.27
Price to Cash Flow (P/CF)-0.90
P/FCF Ratio2.50
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.28
Enterprise Value/Gross Profit2.29
Enterprise Value/Ebitda6.77
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

46.71%0.00%0.11%53.18%
46.71% Insiders
0.11% Other Institutional Investors
53.18% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

EMMA FAQ

What was Emmaus Life Sciences Inc’s price range in the past 12 months?
Emmaus Life Sciences Inc lowest stock price was $0.05 and its highest was $0.29 in the past 12 months.
    What is Emmaus Life Sciences Inc’s market cap?
    Currently, no data Available
    When is Emmaus Life Sciences Inc’s upcoming earnings report date?
    Emmaus Life Sciences Inc’s upcoming earnings report date is Aug 12, 2024 which is in 52 days.
      How were Emmaus Life Sciences Inc’s earnings last quarter?
      Currently, no data Available
      Is Emmaus Life Sciences Inc overvalued?
      According to Wall Street analysts Emmaus Life Sciences Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Emmaus Life Sciences Inc pay dividends?
        Emmaus Life Sciences Inc does not currently pay dividends.
        What is Emmaus Life Sciences Inc’s EPS estimate?
        Emmaus Life Sciences Inc’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Emmaus Life Sciences Inc have?
        Emmaus Life Sciences Inc has 53,637,554 shares outstanding.
          What happened to Emmaus Life Sciences Inc’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Emmaus Life Sciences Inc?
          Among the largest hedge funds holding Emmaus Life Sciences Inc’s share is Gibson Capital, Llc. It holds Emmaus Life Sciences Inc’s shares valued at N/A.
            ---

            Company Description

            Emmaus Life Sciences Inc

            Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company. It engages in the discovery, development, marketing and sale of innovative treatments and therapies, including those in the rare and orphan disease categories. The company is headquartered in Torrance, CA.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            Avrobio
            Genetic Technologies
            Kura Oncology
            RegenXBio
            Popular Stocks
            ---
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis